Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023685003> ?p ?o ?g. }
- W2023685003 endingPage "65" @default.
- W2023685003 startingPage "59" @default.
- W2023685003 abstract "Background Several studies have reported elevated levels of fractional exhaled nitric oxide (FeNO) in atopic patients, particularly in asthmatic patients, suggesting that FeNO is a marker of bronchial inflammation. However, the independent influence of different atopic entities (eczema, allergic rhinitis, and asthma) on FeNO has never been studied in the general population. Objective To study the influence of a questionnaire-based diagnosis of atopic diseases and IgE and lung function measurements on FeNO levels. Methods This study was part of a follow-up on otitis media of a birth cohort of 1,328 children born in Nijmegen, the Netherlands, between September 1, 1982, and August 31, 1983. Within the birth cohort, the incidence of asthma, allergic rhinitis, and eczema was determined, and off-line FeNO, spirometry, and IgE measurements were performed at the age of 21 years. Results FeNO measurements were successfully performed in 361 participants. Median FeNO levels were significantly higher in those with vs without eczema (23.6 vs 18.0 ppb; P < .0001), those with vs without allergic rhinitis (20.7 vs 17.8 ppb; P = .0001), and those with vs without atopic asthma (23.3 vs 18.1 ppb; P = .02) but not in those with vs without asthma (20.8 vs 18.3 ppb; P = .24). Eczema, allergic rhinitis, smoking, sex, and atopic sensitization appeared to be independently associated with log FeNO in this population sample, whereas (atopic) asthma was not. No effect on FeNO levels was observed for lung function parameters. Conclusion Eczema, allergic rhinitis, and atopic status were all independently associated with elevated FeNO levels, whereas (atopic) asthma was not. This finding implies that future studies into the role of FeNO in asthma should consider the influence of atopic disease outside the lungs. Several studies have reported elevated levels of fractional exhaled nitric oxide (FeNO) in atopic patients, particularly in asthmatic patients, suggesting that FeNO is a marker of bronchial inflammation. However, the independent influence of different atopic entities (eczema, allergic rhinitis, and asthma) on FeNO has never been studied in the general population. To study the influence of a questionnaire-based diagnosis of atopic diseases and IgE and lung function measurements on FeNO levels. This study was part of a follow-up on otitis media of a birth cohort of 1,328 children born in Nijmegen, the Netherlands, between September 1, 1982, and August 31, 1983. Within the birth cohort, the incidence of asthma, allergic rhinitis, and eczema was determined, and off-line FeNO, spirometry, and IgE measurements were performed at the age of 21 years. FeNO measurements were successfully performed in 361 participants. Median FeNO levels were significantly higher in those with vs without eczema (23.6 vs 18.0 ppb; P < .0001), those with vs without allergic rhinitis (20.7 vs 17.8 ppb; P = .0001), and those with vs without atopic asthma (23.3 vs 18.1 ppb; P = .02) but not in those with vs without asthma (20.8 vs 18.3 ppb; P = .24). Eczema, allergic rhinitis, smoking, sex, and atopic sensitization appeared to be independently associated with log FeNO in this population sample, whereas (atopic) asthma was not. No effect on FeNO levels was observed for lung function parameters. Eczema, allergic rhinitis, and atopic status were all independently associated with elevated FeNO levels, whereas (atopic) asthma was not. This finding implies that future studies into the role of FeNO in asthma should consider the influence of atopic disease outside the lungs." @default.
- W2023685003 created "2016-06-24" @default.
- W2023685003 creator A5015719837 @default.
- W2023685003 creator A5016554164 @default.
- W2023685003 creator A5035195059 @default.
- W2023685003 creator A5053996737 @default.
- W2023685003 creator A5071426349 @default.
- W2023685003 date "2008-01-01" @default.
- W2023685003 modified "2023-10-17" @default.
- W2023685003 title "Atopic disease and exhaled nitric oxide in an unselected population of young adults" @default.
- W2023685003 cites W1853770523 @default.
- W2023685003 cites W1964187430 @default.
- W2023685003 cites W1964261404 @default.
- W2023685003 cites W1967032540 @default.
- W2023685003 cites W1971600950 @default.
- W2023685003 cites W1978460691 @default.
- W2023685003 cites W1980526114 @default.
- W2023685003 cites W1983595439 @default.
- W2023685003 cites W1984249676 @default.
- W2023685003 cites W1992105306 @default.
- W2023685003 cites W1994145602 @default.
- W2023685003 cites W2023892656 @default.
- W2023685003 cites W2025797926 @default.
- W2023685003 cites W2026833709 @default.
- W2023685003 cites W2028730911 @default.
- W2023685003 cites W2031166571 @default.
- W2023685003 cites W2036685335 @default.
- W2023685003 cites W2040134982 @default.
- W2023685003 cites W2060154445 @default.
- W2023685003 cites W2075434784 @default.
- W2023685003 cites W2078348184 @default.
- W2023685003 cites W2080741303 @default.
- W2023685003 cites W2134845155 @default.
- W2023685003 cites W2142010704 @default.
- W2023685003 cites W2144175743 @default.
- W2023685003 cites W2152124670 @default.
- W2023685003 cites W2152221379 @default.
- W2023685003 cites W2155776366 @default.
- W2023685003 cites W2156916241 @default.
- W2023685003 cites W2157430977 @default.
- W2023685003 cites W2160515650 @default.
- W2023685003 cites W2162452275 @default.
- W2023685003 cites W2170413821 @default.
- W2023685003 cites W2604596332 @default.
- W2023685003 cites W4211006694 @default.
- W2023685003 doi "https://doi.org/10.1016/s1081-1206(10)60406-1" @default.
- W2023685003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18254484" @default.
- W2023685003 hasPublicationYear "2008" @default.
- W2023685003 type Work @default.
- W2023685003 sameAs 2023685003 @default.
- W2023685003 citedByCount "34" @default.
- W2023685003 countsByYear W20236850032012 @default.
- W2023685003 countsByYear W20236850032013 @default.
- W2023685003 countsByYear W20236850032014 @default.
- W2023685003 countsByYear W20236850032015 @default.
- W2023685003 countsByYear W20236850032019 @default.
- W2023685003 countsByYear W20236850032021 @default.
- W2023685003 countsByYear W20236850032022 @default.
- W2023685003 crossrefType "journal-article" @default.
- W2023685003 hasAuthorship W2023685003A5015719837 @default.
- W2023685003 hasAuthorship W2023685003A5016554164 @default.
- W2023685003 hasAuthorship W2023685003A5035195059 @default.
- W2023685003 hasAuthorship W2023685003A5053996737 @default.
- W2023685003 hasAuthorship W2023685003A5071426349 @default.
- W2023685003 hasConcept C120665830 @default.
- W2023685003 hasConcept C121332964 @default.
- W2023685003 hasConcept C126322002 @default.
- W2023685003 hasConcept C141105273 @default.
- W2023685003 hasConcept C159654299 @default.
- W2023685003 hasConcept C203014093 @default.
- W2023685003 hasConcept C207480886 @default.
- W2023685003 hasConcept C2776042228 @default.
- W2023685003 hasConcept C2777697326 @default.
- W2023685003 hasConcept C2780333948 @default.
- W2023685003 hasConcept C2781142857 @default.
- W2023685003 hasConcept C2908647359 @default.
- W2023685003 hasConcept C61511704 @default.
- W2023685003 hasConcept C71924100 @default.
- W2023685003 hasConcept C72563966 @default.
- W2023685003 hasConcept C90924648 @default.
- W2023685003 hasConcept C99454951 @default.
- W2023685003 hasConceptScore W2023685003C120665830 @default.
- W2023685003 hasConceptScore W2023685003C121332964 @default.
- W2023685003 hasConceptScore W2023685003C126322002 @default.
- W2023685003 hasConceptScore W2023685003C141105273 @default.
- W2023685003 hasConceptScore W2023685003C159654299 @default.
- W2023685003 hasConceptScore W2023685003C203014093 @default.
- W2023685003 hasConceptScore W2023685003C207480886 @default.
- W2023685003 hasConceptScore W2023685003C2776042228 @default.
- W2023685003 hasConceptScore W2023685003C2777697326 @default.
- W2023685003 hasConceptScore W2023685003C2780333948 @default.
- W2023685003 hasConceptScore W2023685003C2781142857 @default.
- W2023685003 hasConceptScore W2023685003C2908647359 @default.
- W2023685003 hasConceptScore W2023685003C61511704 @default.
- W2023685003 hasConceptScore W2023685003C71924100 @default.
- W2023685003 hasConceptScore W2023685003C72563966 @default.
- W2023685003 hasConceptScore W2023685003C90924648 @default.
- W2023685003 hasConceptScore W2023685003C99454951 @default.